CheckMyRecalls

Ajanta Pharma USA Inc recalls Fluphenazine Hydrochloride Tablets

Published
16 Sept 2026
Units affected
403,200 tablets
Agency
FDA
Country
United States

The hazard

Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent. Spec: 1.0 percent.

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-255-01.

Brand / company
Ajanta Pharma USA Inc
Codes / lots
Lot #: DJ23254, Exp. Date 11/30/2026; DJ10205, Exp. Date 04/30/2027.
Distribution
Nationwide within the U.S
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 16 Sept 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.